Stay updated with breaking news from Mediated Rejection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Commercial launch and market access efforts in Europe progressing as planned; New multiregional commercialization partnership with Medison in...
/PRNewswire/ -- Commercial launch and market access efforts in Europe progressing as planned; New multiregional commercialization partnership with Medison in...
Antibody-mediated Rejection Market to Exhibit a Healthy CAGR of 17.5% During the Forecast Period, Affirms DelveInsight LAS VEGAS, March 9, 2021 /PRNewswire/ -- DelveInsight's " Antibody-mediated Rejection (AMR) Market" report provides a thorough comprehension of the Antibody-mediated Rejection, historical and forecasted epidemiology, and the AMR market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Antibody-mediated Rejection market report also proffers an analysis of recent Antibody-mediated Rejection treatment algorithm/practice...
® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was reinitiated in December 2020 Year-end cash position of SEK 1.4 billion LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced a business update for the fourth quarter 2020 and certain preliminary, unaudited key financials for its financial year 2020. The Company will be participating in the JP Morgan Global Healthcare Conference in San Francisco from January 11 to 14, 2021, with a corporate presentat...